Limited efficacy of common local anaesthetic
Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain. The medication is...
Read MoreFirst ever medicine decommissioned on environmental grounds
NHS England has decommissioned desflurane because of its global warming potential. Desflurane is a general anaesthetic that has a global...
Read MoreKarger Publishers launches its fifth annual Vesalius Innovation Award to advance health sciences
For the fifth consecutive year, Karger Publishers is seeking top-of-the-line applicants for its Vesalius Innovation Award. The award is aimed...
Read MoreChronic pain linked to socioeconomic background
Development of chronic musculoskeletal pain can be influenced by socioeconomics, fear of movement, smoking and poorer support networks, new research...
Read MoreA small robot car can reduce children’s stress before surgery
Undergoing medical treatment, having surgery or simply being admitted to hospital are situations that make children fearful and anxious, especially...
Read MoreDeveloping an international consensus on future pandemic preparedness
A pioneering international collaboration, led jointly by a Teesside University academic, has identified new research priorities needed to prepare for...
Read MoreFuture vaccine makers to get VR-assisted training centre of excellence
Future medicine and vaccine makers will be able to develop their skills using virtual reality thanks to a new national...
Read MoreAction® Pressure Management Range available from Central Medical Supplies
Promotional feature The Action® range of pressure ulcer prevention products is exclusively available in the UK from Central Medical Supplies...
Read More